The final article summarizing the results of Enantis’ SME Instrument H2020 project has been published on CORDIS website today. The piece called “Improving the use of fibroblast growth factor products for therapeutic applications“ is translated into six different languages and talks about our motivation to start the project, the results achieved and the experience gained during the grant period. We received the full amount of EUR 1,030,000 from the grant budget and managed to enter the global distribution deal with one of our products.

Find the article here

Thanks for the opportunity.

Over the next few months, this interview series will introduce the people behind Enantis. The first part of the series is about Táňa Fidlerová, our tissue culture lab technician.

WHEN DID YOU JOIN ENANTIS?
A year and a bit back.

WHAT ARE YOUR TASKS HERE?
I am making sure the cell culture lab runs smoothly. Mainly, I take care of the cell cultures and perform biological activity testing of our newly developed recombinant proteins.

HOW DID YOU GET HERE?
I was searching for a job in a young and dynamic biotech company and luckily, I came across the Enantis job ad.

WHAT IS YOUR MOST FAVOURITE JOB TASK?
I cannot name just one. I like that I am part of the development process from the experimental design to the evaluation of the final results.

HOW DO YOU ENJOY YOUR FREE TIME?
I perform all kinds of sports, hike in the mountains or attend pub quizzes.

WHAT ARE YOU LOOKING FORWARD TO RIGHT NOW?
I look forward to my holidays in the Austrian Alps.

FAVOURITE COLOUR?
Yellow.

FOOD?
Anything I do not have to prepare.

DRINK?
Anything cold right now.

PLACE?
Somewhere with as few people as possible.

THANK YOU FOR THE LOVELY INTERVIEW, TÁŇA!!!

Today, our Chief Scientific Officer Radka Chaloupkova was interviewed at the Czech National TV (Česká televize) for the programme Sama doma. The interview was focused on her research in the field of growth factor production and chronic wound healing.

Check it out (only in Czech): https://bit.ly/2U2l7mj

Let’s celebrate – thanks to the EU funding we are on a global market!

For the past two years, Enantis has worked under the prestigious EU grant SME Instrument. We are one of the two Czech companies that were awarded Phase II funding and the only biotech company. For this reason, Enantis is extremely proud to announce that the project was successfully finished and evaluated by the experts and the results are just magnificent. Well, read the first sentence of our evaluation report for yourself:

“Project has delivered exceptional results with significant immediate or potential impact”

The SME Instrument provided us with structure, funds, and advice necessary to develop and launch our exquisite product globally. The FGF2-STAB, hyperstable fibroblast growth factor 2, is now being sold worldwide and we receive just positive feedback. (By the way, let us know if you want to buy it, we will point you in the direction of our distributor).

This is not the end though, we are already on a mission to stabilise more molecules to be used in stem cell cultivation and tissue regeneration.

Stay tuned !!!

Enantis was invited to participate at the European Innovation Council Seminar that will take place in Prague on 13th of June (9.00 – 13.00) in the conference room of the European House. Our CEO, Roman Badik, is going to present our success story.

More info can be found in the attached leaflet (in Czech), although the seminar is held in English. If you are interested in attending, please, register at the following email address: comm-rep-cz-conference@ec.europa.eu

We will be happy to meet you there.